Status:
RECRUITING
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
Lead Sponsor:
Emory University
Conditions:
Small-cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)
Detailed Description
To determine the optimal schedule for three-dimensional verification imaging and necessary re-planning of patients undergoing IMPT for a rapidly changing tumor (small cell lung cancer). * To determin...
Eligibility Criteria
Inclusion
- Pathologically confirmed small cell lung cancer, limited or extensive stage.
- Patients who are offered thoracic radiotherapy with intensity-modulated proton therapy (IMPT) techniques delivering 30-66 Gy in 15-33 fractions at 2 Gy per fraction, at the recommendation of the treating radiation oncologist.
- Age 18 or greater
Exclusion
- Prior radiation therapy which would provide significant dose overlap with the planned target volume(s)
- Pregnancy
Key Trial Info
Start Date :
March 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 27 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04342429
Start Date
March 19 2020
End Date
May 27 2027
Last Update
July 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Winship Cancer Institute
Atlanta, Georgia, United States, 30322